In clinical practice, I repeatedly encounter the terms psychosomatic illness, functional somatic syndrome, and somatoform disorder being used interchangeably — or, conversely, strictly separated without any clear rationale. This terminological ambiguity is not merely an academic problem: it has direct consequences for how we conceptualize the patient, what diagnostic procedures we choose, and — not least — how we communicate our diagnostic reasoning to the patient. I will therefore attempt to offer a conceptual map that may prove useful in clinical practice.
Psychosomatic illness: the psyche as a modulator of organic pathology
The oldest of these terms — and paradoxically the one that today carries the greatest terminological burden — is psychosomatic illness. In its classical sense, it denotes a somatic disease with a demonstrable organic substrate whose onset, course, or exacerbation is significantly co-determined by psychological and social factors. Canonical examples include bronchial asthma, essential hypertension, peptic ulcer, ulcerative colitis, and atopic dermatitis.
The key feature of this concept is that the organic lesion or dysfunction is objectively demonstrable — the psychological factor does not replace it but co-shapes it. In this sense, psychosomatic illness is a natural product of the biopsychosocial model: the psyche acts as a variable in the multifactorial etiology of disease, not as its sole cause.
The problem is that, as a consequence of the biopsychosocial model's expansion into general medicine, the term psychosomatic illness has largely lost its distinctive value. Today, one could argue that virtually every chronic somatic disease is in some sense "psychosomatic" — psychological factors modulate immune responses, inflammatory processes, treatment adherence, and quality of life. When I use the term, I therefore try to specify in what capacity — whether as shorthand for a biopsychosocial formulation or as a label for a specific group of diseases.
Functional somatic syndrome: symptoms without sufficient organic explanation
Functional somatic syndrome (FSS) refers to constellations of bodily symptoms for which we find no sufficient structural or biochemical explanation and which nonetheless cluster into clinically recognizable patterns. Examples include irritable bowel syndrome (IBS), fibromyalgia, chronic fatigue syndrome (ME/CFS), and chronic tension-type headache.
FSS is defined in two ways simultaneously: negatively (absence of a sufficiently demonstrable organic cause) and positively (a typical symptom profile that constitutes the given syndrome). Unlike psychosomatic illness, we typically find no structural correlate here that would adequately account for the extent of the complaints — the symptom itself is the clinically relevant phenomenon, not the manifestation of a hidden disease. This alone, however, says nothing definitive about etiology.
Crucially, the FSS label is etiologically agnostic. It does not claim that psychological causes underlie the symptoms — it opens space for various hypotheses: central sensitization and disturbances in sensory signal processing, autonomic dysregulation, low-grade inflammation, or combinations thereof. In the current literature, the umbrella term central sensitivity syndromes (CSS) has become established for the group of syndromes sharing a central sensitization mechanism (FSS, fibromyalgia, ME/CFS, and related conditions), which enhances the biological validity of this concept. Some researchers proposed the FSS category precisely to circumvent the psychosomatic mind–body dichotomy and to enable descriptive clinical conceptualization without etiological prejudice.
From a clinical standpoint, this distinction is particularly important in relation to the patient: labeling a condition as FSS is more tolerable for many patients than implying that they are "making it up" or that their problem is "merely psychological." This approach legitimizes the patient's subjective suffering without necessarily psychologizing their condition.
Somatoform disorders, SSD, and bodily distress disorder: a psychopathological superstructure across classification systems
Somatoform disorders in ICD-10 (F45) represent a historically older category that adds specific psychological and behavioral criteria to a clinical picture similar to FSS. DSM-5 renamed and reconceptualized this group as somatic symptom disorder (SSD), and the latest ICD-11 introduced the analogous category bodily distress disorder (code 6C20; note that the abbreviation BDD is not used here to avoid confusion with body dysmorphic disorder). These are therefore three partially overlapping yet not fully equivalent nosological frameworks, reflecting the gradual evolution in our understanding of these conditions.
All three systems agree that a specific psychological and behavioral dimension is added to the clinical picture: persistent and excessive concerns about bodily symptoms; catastrophic cognitive processing (convictions about severity, incurability, etc.); and maladaptive behavior associated with symptoms (repeated reassurance-seeking, compulsive body-checking, excessive healthcare utilization, or conversely avoidance behavior).
DSM-5 brought a fundamental shift in this regard: the criterion of "medically unexplained symptoms" was de-emphasized in favor of the criterion of a disproportionate psychological relationship to symptoms — symptoms must typically persist for longer than 6 months. In other words: even a patient with an organically based symptom (for example, pain in the context of a verified oncological diagnosis) can meet SSD criteria if their cognitive-behavioral response is dysfunctional. ICD-11 moved in the same direction with its bodily distress disorder category: the diagnosis is possible even when another medical condition contributes to the symptoms, provided the degree of preoccupation with symptoms is clearly disproportionate.
An important clinical conclusion follows: not every FSS meets the criteria for somatoform disorder, SSD, or bodily distress disorder. A patient with IBS who suffers from intestinal symptoms, understands their functional nature well, manages them adaptively, and does not seek excessive healthcare does not meet these criteria. Somatoform disorder (or SSD, or bodily distress disorder) presupposes specific psychopathology beyond the somatic symptoms themselves.
For psychodiagnostics, this implies a requirement: it is not sufficient to capture somatic symptoms and their intensity — one must systematically assess illness-related cognitive schemas, the degree of health anxiety, safety behaviors, and overall adaptive functioning.
Dissociative and conversion disorders: a different mechanism, similar phenomenology
Conversion disorder (classified among dissociative disorders in ICD-10 as F44, renamed functional neurological symptom disorder in DSM-5, and listed as dissociative neurological symptom disorder in ICD-11) shares with FSS the absence of a sufficient organic substrate, but the mechanism is fundamentally different. It involves neurological symptoms — motor (pareses, tremor, gait disturbances), sensory, or paroxysmal (non-epileptic seizures) — in which a dissociative mechanism is presumed: a disruption in the integration of motor or sensory processing at the level of functional neurological networks. Current neurology refers to this entity as functional neurological disorder (FND) and emphasizes that the diagnosis should not rest solely on the absence of organic findings, but on positive clinical signs — for example, Hoover's sign in functional paresis, which demonstrates an incongruence of motor activity depending on voluntary versus automatic control.
Dissociative disorders in the broader sense (depersonalization/derealization, dissociative amnesia, dissociative identity disorder) share with FSS the feature that the symptom is not caused by a structural lesion, but the mechanism belongs to a different domain: what predominates is a disruption in the integration of consciousness, identity, memory, or body schema.
The boundary between FSS and dissociative/conversion states is sometimes porous in clinical practice. Patients with chronic FSS frequently have a history of traumatic experiences and exhibit statistically higher dissociative capacity. Trauma, dissociation, and functional somatization can coexist and mutually reinforce one another — which has obvious implications for the choice of therapeutic approach.
Schematic comparison
DimensionPsychosomatic illnessFunctional somatic syndrome (FSS)Somatoform disorder / SSD / bodily distress disorderDissociative / Conversion (FND)Organic lesionyesinsufficiently demonstratedno (or irrelevant in DSM-5 and ICD-11)noPsychiatric criteria requirednonoyesyesPresumed mechanismbiopsychosocial modulation of organic pathologycentral sensitization, autonomic dysregulationcognitive-behavioral dysfunction, health anxietydissociation, disrupted integrationEtiological stancemultifactorialagnosticpsychological superstructure over FSSdissociative / traumaticClinical domaininternal medicine + consultation-liaison psychiatryvarious medical specialtiespsychiatry / psychologyneurology + psychiatry
Clinical conclusions
For everyday practice, several useful orienting points follow from the above.
First, psychosomatic illness and FSS are not synonyms — the former presupposes an organic basis modulated by the psyche, the latter the absence of a sufficient organic explanation. Conflating the two leads to different diagnostic procedures and different ways of communicating with the patient.
Second, FSS is not a psychological diagnosis — it is a clinical descriptor that says nothing about causes. Psychologizing a patient with FSS without further assessment of their psychological state is an additional step that requires justification.
Third, SSD and bodily distress disorder cannot be established merely by noting the absence of an organic cause — they require active assessment of psychopathology. Health anxiety, catastrophizing, and safety behaviors are clinically measurable constructs. Valid psychometric instruments are available: for capturing the burden of somatic symptoms, particularly the PHQ-15; for the domain of health anxiety, the Whiteley Index (WI) or the Short Health Anxiety Inventory (SHAI).
Fourth, dissociation and somatization are not mutually exclusive — particularly in patients with a traumatic history, it is meaningful to work with both dimensions and not rely on an exclusively somatic or exclusively dissociative framework. The diagnosis of FND, moreover, rests not solely on the absence of organic findings, but on positive demonstration of functional incongruence.
Terminological precision in this field is therefore not an academic luxury — it is a prerequisite for meaningful diagnostic formulation and therapeutic planning. And if updated classification frameworks (DSM-5, ICD-11) are available to us, it is appropriate to work with them deliberately — even when traditional terms such as "somatoform disorder" remain alive in clinical parlance.
This article serves educational purposes and does not constitute a diagnostic tool. Assessment of somatic symptom disorder, bodily distress disorder, or functional neurological disorder requires a comprehensive clinical evaluation including standardized diagnostic instruments and an assessment of functional impact.
